Medical University of South Carolina Hematology-Oncology Division — Charleston, South Carolina

Medical University of South Carolina Hematology-Oncology Division is a clinical research site located in Charleston, South Carolina, United States 29425.

Crixeo Health Trust Score: 44/100 (POOR). This profile has not yet been claimed by the site owner.

Medical University of South Carolina Hematology-Oncology Division has participated in 1 clinical trials.

Therapeutic areas: Acute Myeloid Leukemia (AML) With, FLT3 Mutation, Internal Tandem Duplication (ITD) or Tyrosine Kinase Domain (TKD).

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 44/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Medical University of South Carolina Hematology-Oncology Division?

Medical University of South Carolina Hematology-Oncology Division has a Crixeo Trust Score of 44/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Medical University of South Carolina Hematology-Oncology Division conducted?

Medical University of South Carolina Hematology-Oncology Division has 1 clinical trials on record. Their work covers Acute Myeloid Leukemia (AML) With, FLT3 Mutation, Internal Tandem Duplication (ITD) or Tyrosine Kinase Domain (TKD).

Is Medical University of South Carolina Hematology-Oncology Division accredited by Crixeo Health?

Medical University of South Carolina Hematology-Oncology Division has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Medical University of South Carolina Hematology-Oncology Division?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.